These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Role of antigen size and charge in immune complex glomerulonephritis. Isaacs KL; Miller F Lab Invest; 1982 Aug; 47(2):198-205. PubMed ID: 6180247 [TBL] [Abstract][Full Text] [Related]
4. Case report: paclitaxel-induced myocardial ischemia. Soe MS; Berkman A; Mardelli TJ Md Med J; 1996 Jan; 45(1):41-3. PubMed ID: 8569460 [No Abstract] [Full Text] [Related]
5. Limited cutaneous systemic sclerosis induced by paclitaxel in a patient with breast cancer. Kawakami T; Tsutsumi Y; Soma Y Arch Dermatol; 2009 Jan; 145(1):97-8. PubMed ID: 19153362 [No Abstract] [Full Text] [Related]
6. Nurses should monitor cutaneous toxicity in chemotherapy regimens with paclitaxel. Knobf MT; Staugaard C Oncol Nurs Forum; 1997 Sep; 24(8):1328. PubMed ID: 9380582 [No Abstract] [Full Text] [Related]
7. Peripheral neuropathy in a woman with breast cancer. Cianfrocca M; Flatters SJ; Bennett GJ; McNicol E; Relias V; Carr D; Gillis TA J Pain; 2006 Jan; 7(1):2-10. PubMed ID: 16414547 [No Abstract] [Full Text] [Related]
9. Programmed death 1 and its ligands do not limit experimental foreign antigen-induced immune complex glomerulonephritis. Ooi JD; Li M; Kourkoutzelos K; Yagita H; Azuma M; Holdsworth SR; Kitching AR Nephrology (Carlton); 2015 Dec; 20(12):892-8. PubMed ID: 26043977 [TBL] [Abstract][Full Text] [Related]
10. Glaucoma and paclitaxel. De Giorgi U; Acciarri R; Fiorentini G; Rosti G; Marangolo M Lancet; 2000 Jan; 355(9199):231. PubMed ID: 10675141 [No Abstract] [Full Text] [Related]
13. Histopathological improvement of scleroderma induced by paclitaxel in a patient with breast cancer. Ohashi A; Minagawa A; Ashida A; Koga H; Uhara H; Okuyama R J Dermatol; 2015 Dec; 42(12):1198-9. PubMed ID: 26333146 [No Abstract] [Full Text] [Related]
14. Paclitaxel-induced pancreatitis: a case report. Hoff PM; Valero V; Holmes FA; Whealin H; Hudis C; Hortobagyi GN J Natl Cancer Inst; 1997 Jan; 89(1):91-3. PubMed ID: 8978416 [No Abstract] [Full Text] [Related]
15. Recall phenomena: another facet of the immunocompromised district. Ruocco V; Ruocco E; Brunetti G Int J Dermatol; 2013 Feb; 52(2):252-3. PubMed ID: 23347316 [No Abstract] [Full Text] [Related]
16. Fatal hepatic coma attributed to paclitaxel. Feenstra J; Vermeer RJ; Stricker BH J Natl Cancer Inst; 1997 Apr; 89(8):582-4. PubMed ID: 9106649 [No Abstract] [Full Text] [Related]
17. Paclitaxel-induced neutrophilic adverse reaction and acral erythema. Cruz A; Temu T; Hines-Telang G; Kroumpouzos G Acta Derm Venereol; 2011 Jan; 91(1):86-7. PubMed ID: 21031283 [No Abstract] [Full Text] [Related]
18. Dose-intensified weekly paclitaxel induces multiple nail disorders. Lüftner D; Flath B; Akrivakis C; Schweigert M; Prinz B; Mergenthaler HG; Petrides PE; Wernecke KD; Possinger K Ann Oncol; 1998 Oct; 9(10):1139-40. PubMed ID: 9834830 [No Abstract] [Full Text] [Related]